Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Taminco (NYSE: TAM) were looking brighter today, gaining as much 13% after a promising quarterly earnings report, its first as a public company.
So what: The world's largest alkylamine maker, and supplier for industries ranging from agriculture to oil and gas to personal care, said net sales were up 10% to a record $310 million, and volume increased 7% to 144,000 tons. Earnings per share came in at $0.16, a huge turnaround from a year ago, when the company had a loss of $0.88 a share. Gross profit increased by more than 600% from a year ago. Estimates were unavailable for the newly public company, but CEO Laurent Lenoir touted the company's "successful execution of recent growth projects in North America."
Now what: Lenoir noted that first-quarter performance was strong in nearly every segment except crop protection, which was affected by adverse weather conditions. Looking ahead, he sees record EBITDA for the year but did not give a range on any financial numbers such as revenue and earnings per share. The funds from the recent IPO should help alleviate the company's interest expense and fuel future growth, but I'd like to see the top line grow faster than 10% before getting on board.
Top Wireless Telecom Companies To Watch In Right Now: Immunomedics Inc.(IMMU)
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. The company?s products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkin?s lymphoma; Veltuzumab, a Phase I/II clinical study completed product for the treatment of patients with non-Hodgkin?s lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib/II clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkin?s lymphoma. Its early phase clinical trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug conjugate therapy. The com pany also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers. In addition, it markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. Immunomedics, Inc. has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd., to develop vaccines against cancers that include melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Immunomedics (NASDAQ: IMMU ) , a biopharmaceutical company researching monoclonal, antibody-based products to treat cancer and other autoimmune disorders, jumped as much as 15% after providing a clinical update on its antibody-drug conjugate programs.
5 Best Promising Stocks To Watch For 2014: Owens & Minor Inc.(OMI)
Owens & Minor, Inc., together with its subsidiaries, provides distribution, third-party logistics, and other supply-chain management services to healthcare providers and suppliers of medical and surgical products. Its services include logistics, supplier management, analytics inventory management, outsourced resource management, clinical supply management, and business process consulting. The company also offers various services comprising PANDAC, an operating room-focused inventory management program that helps healthcare providers to control suture and endo-mechanical inventory; SurgiTrack, a customizable surgical supply service that includes the assembly and delivery of surgical supplies in procedure-based totes; OMSolutions, a supply-chain consulting, customer technology, and resource management service; and WISDOM Gold, an Internet-based supply spend management, data normalization, and contract management solution. In addition, it provides Clinical Supply Solutions, a n inventory and contract management service; and Implant Purchase Manager, a technology-based service, as well as owns OM HealthCare Logistics, a customized third-party logistics and business process outsourcing service. Further, the company distributes medical and surgical supplies to the acute-care market. It serves federal government, including the U.S. department of defense; and alternate-site providers, such as ambulatory surgery centers, physicians? practices, clinics, home healthcare organizations, nursing homes, and rehabilitation facilities, as well as provides distribution and supply-chain management services that include third-party logistics and business process outsourcing services to manufacturers of medical and surgical products. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Owens & Minor (NYSE: OMI ) , whose recent revenue and earnings are plotted below. - [By Chris Mydlo]
Owens & Minor Inc. (OMI) is trading at a low P/S ratio of 0.20, near its 10-year low of 0.18. The company offers supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies, and devices. It is held by 14 gurus we follow.
- [By Dividends4Life]
Memberships and Peers: CAH is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers��Index. The company's peer group includes: AmerisourceBergen Corporation (ABC) with a 1.3% yield, McKesson Corporation (MCK) with a 0.6% yield and Owens & Minor Inc. (OMI) with a 2.5% yield.
5 Best Promising Stocks To Watch For 2014: TASER International Inc.(TASR)
TASER International, Inc. develops, manufactures, and sells electronic control devices (ECD) for use in the law enforcement, military, corrections, private security, and personal defense markets. ECDs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. Its products for the law enforcement, military, corrections, and professional security market include the TASER X26 product line, which consists of TASER X26, various cartridges, a digital power magazine, data download software and equipment, extended warranties, and a range of holstering options and accessories; TASER X3, a multi-shot ECD that would engage three separate targets; and ADVANCED TASER M26 product line comprising the ADVANCED TASER M26, various cartridges, rechargeable batteries, a battery charging system, data download software and equipment, extended warranties, and various holstering options and accessories. The company also provides TASER XREP, a self-contained, wireless ECD that deploys from a 12-gauge pump-action shotgun; and TASER Shockwave security system for safety and stand-off capability during hostile situations. In addition, it manufactures TASER C2, TASER X26C, and ADVANCED TASER M26C devices for the personal defense market, as well as provides various cartridges and other accessories. The company sells its products worldwide through its direct sales force, distribution partners, online store, and third-party resellers. TASER International, Inc. was founded in 1993 and is headquartered in Scottsdale, Arizona.
Advisors' Opinion:- [By Lee Jackson]
TASER International Inc. (NASDAQ: TASR) is on a growth path, having reported double-digit revenue increases for eight quarters in a row. The company claims to produce “the world’s safest and most effective weapons” that are becoming popular with the U.S. police departments. TASER’s stun guns practically have no serious competition. J.P. Morgan has a $20 target, and the consensus target is $20.33. TASER closed Tuesday at $18.50.
- [By Ben Levisohn]
Taser International (TASR) has risen 6.1% to $20.26 after the maker of non-lethal weapons reported earnings of 13 cents a share, more than double analyst forecasts.
- [By Rich Smith]
In its latest update on stun-gun sales, TASER International (NASDAQ: TASR ) reported Wednesday that it has booked several new orders for its eponymous stun guns. These orders should ship in the current first fiscal quarter of 2014 and will show up in this quarter's revenues when earnings are next released. Specifically, TASER has sold:
- [By Jon C. Ogg]
TASER International Inc. (NASDAQ: TASR) was downgraded to Neutral from Overweight at J.P. Morgan.
Tiffany & Co. (NYSE: TIF) was downgraded to Neutral from Buy at Citigroup.
5 Best Promising Stocks To Watch For 2014: Cal-Maine Foods Inc (CALM)
Cal-Maine Foods, Inc., incorporated on September 10, 1969, is a producer and marketer of shell eggs in the United States. During the fiscal year ended June 1, 2013 (fiscal 2013), the Company sold approximately 948.5 million dozen shell eggs. Its primary business is the production, grading, packaging, marketing and distribution of shell eggs. It sells most of its shell eggs in the southwestern, southeastern, mid-western and mid-Atlantic regions of the United States. The Company markets its shell eggs through its distribution network to a group of customers, including national and regional grocery store chains, club stores, foodservice distributors and egg product manufacturers. It sells shell eggs to a majority of the food retailers in the United States. It is also a producers and marketers of specialty shell eggs in the United States. Specialty shell eggs include cage free and organic eggs. The Company owns 100% of Benton County Foods, LLC. In March 2014, the Company acquired 50% interests of Delta Egg Farm, LLC from Sunbest Foods of Iowa, Inc., a Moark, LLC affiliate, as result Delta Egg Farm, LLC, is a wholly owned subsidiary of the Company.
The Company markets its specialty shell eggs under various brands, such as Egg-Land�� Best, Land O��Lake, Farmhouse, and 4-Grain. It also produces specialty eggs, such as Egg-Land�� Best, Land O��Lake, Farmhouse, and 4-Grain. It has exclusive license agreements to market and distribute Egg-Land�� Best specialty shell eggs in major metropolitan areas, including New York City, and a number of states in the southeast and southwest. It markets cage free eggs under its trademarked Farmhouse brand and distribute those shell eggs across the southeast and southwest regions of the United States. It markets organic, all natural, cage-free, vegetarian, and omega-3 eggs under its 4-Grain trademark. It also produces market and distributes private label specialty shell eggs to several customers. Sales of specialty shell eggs accounted for approximately ! 16.4% of its total shell egg dozen volumes during fiscal 2013.
The Company�� operations are integrated. At its facilities, it hatches chicks, grows pullets, manufactures feed, and produces and distributes shell eggs. It produces approximately 95% of its chicks in its own hatcheries. It owns breeder facilities producing 18.5 million pullet chicks per year. These pullets are distributed to 42 laying operations around the southwestern, southeastern, mid-western and mid-Atlantic regions of the United States. The facilities produce an average of 1.9 million dozen shell eggs per day and process the shell eggs through grading and packaging without handling by human hands.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top Headline
Cal-Maine Foods (NASDAQ: CALM) reported a 7% drop in its fiscal first-quarter earnings. Cal-Maine's quarterly profit fell to $8.8 million, or $0.36 per share, from $9.4 million, or $0.39 per share, in the year-ago period. - [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
HRL is trading at a premium to all four valuations above. The stock is trading at a 27.6% premium to its calculated fair value of $35.92. HRL did not earn any Stars in this section.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
HRL earned one Star in this section for 2.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1928 and has increased its dividend payments for 48 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:
1. NPV MMA Diff.
2. Years to > MMA
HRL earned a Star in this section for its NPV MMA Diff. of the $984. This amount is in excess of the $500 target I look for in a stock that has increased dividends as long as HRL has. If HRL grows its dividend at 13.2% per year, it will take 7 years to equal a MMA yielding an estimated 20-year average rate of 3.68%.
Memberships and Peers: HRL is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achiever - [By Rich Duprey]
Here's something to get a little bit eggs-cited about: Cal-Maine Foods (NASDAQ: CALM ) agreed to settle a class action price-fixing lawsuit for about $28 million. The country's largest fresh egg producer clucks that it did nothing wrong, but rather that it has agreed to put the matter behind it in the interests of its shareholders.
No comments:
Post a Comment